Ravelcare IPO Details
The key details of Ravelcare’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹24.10 Cr |
| Price Range | ₹123 - ₹130 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | BSE |
| Minimum Quantity | 2,000 |
| Investment (cut-off price) | ₹2,60,000 |
| Pre IPO Promotor Holding | 99.96% |
| Post IPO Promotor Holding | Update soon |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Ravelcare IPO Timelines
The IPO process for Ravelcare includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
01/12/2025
Start Date03/12/2025
End Date05/12/2025
Refund Initiation05/12/2025
Credit of Shares to Demat Ac08/12/2025
Listing DateRavelcare IPO Lot Size
The Ravelcare IPO has a fixed lot size of 2,000 shares, at an upper price band of ₹130 per share. For retail investors, the minimum and maximum application is 2,000 shares (2 lots) amounting to ₹2,60,000. For S-HNI investors, the minimum application is 3,000 shares (3 lots) worth ₹3,90,000, while the maximum is 7,000 shares (7 lots) amounting to ₹9,10,000. B-HNI investors need to apply for at least 8,000 shares (8 lots) totaling ₹10,40,000.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2000 | ₹2,60,000 |
| Retail Maximum | 2 | 2000 | ₹2,60,000 |
| S-HNI Minimum | 3 | 3000 | ₹3,90,000 |
| S-HNI Maximum | 7 | 7000 | ₹9,10,000 |
| B-HNI Minimum | 8 | 8000 | ₹10,40,000 |
Ravelcare IPO Subscription Status
The subscription status for Ravelcare IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 3.52x | 25.81x | 17.89x | -- | 15.50x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹ | ₹ | ₹ | ₹ |
Ravelcare IPO Company Financials
Ravelcare reports robust performance in FY2026 September with Total Income of ₹14.44 crores, managing expenses at ₹10.11 crores, and achieving a strong PAT (Profit After Tax) of ₹3.20 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2023 | ₹3.49 | ₹2.99 | ₹0.41 |
| FY 2024 | ₹22.28 | ₹15.47 | ₹5.02 |
| FY 2025 | ₹25.30 | ₹18.26 | ₹5.26 |
| FY 2026 (6 M) | ₹14.44 | ₹10.11 | ₹3.20 |
About Company
Ravelcare Ltd., incorporated in November 2018, is a digital-first beauty and personal care brand offering a wide range of haircare, skincare, bodycare and scalp care products tailored to individual needs through online platforms including its own website, major marketplaces and quick commerce channels. In FY 2024 – 25 the company expanded internationally to the UAE, Australia, Canada, Germany, the USA and Saudi Arabia, while strengthening logistics and warehousing across central India to ensure efficient delivery. It also plans to establish an integrated manufacturing facility in Mauje Peth, Amravati, Maharashtra with a proposed installed capacity of 1050 TPA to bring research and development, manufacturing, packaging, warehousing and distribution together under one roof.
The company’s offerings span four major segments covering personalised haircare ranging from shampoos to styling products, customised skincare such as cleansers, serums, moisturisers and sunscreens, targeted bodycare including hydrating body washes and lotions and specialised scalp care treatments like anti dandruff tonics and hair growth serums. These products are customised through digital assessments to address concerns including hair fall, frizz, acne, pigmentation, dryness and sensitivity. As of June 30, 2025 Ravelcare employed 25 professionals across its departments.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2018 | Healthcare | Ayush Varma |
Know Before Investing
Ravelcare IPO Strengths
- Ravelcare has seen significant growth in revenue, reflecting expanding market presence and improved business scale.
- The company has broadened its reach internationally, commencing shipments to countries including the UAE, Australia, Canada, Germany, the United States, and Saudi Arabia.
- Ravelcare’s sales through its own website and top e-commerce marketplaces provide direct customer access and higher margins.
- Owning warehousing and logistics operations across central India ensures delivery efficiency and reliable supply chain control.
- The planned manufacturing complex and marketing initiatives will enable scaling operations and strengthening market position.
Ravelcare IPO Risks
- The home care and personal care product market is crowded with established national and international players, posing challenges for market share growth.
- Concentration on online sales exposes the business to platform policy changes, marketing cost variations, and digital consumer behavior risks.
- Delays, cost overruns, or operational issues in setting up the new Amravati complex could impact planned expansion and profitability.
- Heavy depends on a select range of home and personal care products could be a vulnerability if consumer preferences shift.
- Predominantly focused on Indian markets, economic or regulatory changes could affect growth trajectories.
Swot Analysis for Ravelcare IPO
Strengths
Digital-First D2C Model, Personalized Product Solutions, Innovation-Driven Development
Weaknesses
Contract Manufacturing Dependence, Geographic Supply Chain Focus, Static Recent Performance
Opportunities
Integrated Facility Development, Personalization Trends, Product Category Diversification
Threats
Intense Beauty Competition, Regulatory Compliance Risks, Economic Sensitivity
Company Details
Ravelcare Ltd.
Off-126, Neo Corporate Plaza, Cabin B, Ramchandra Lane Extension, Malad, Mumbai, Maharashtra, 400064
Phone: +91 87792 06822
Email: pragya@ravelcare.com
Website: http://www.ravelcare.com/
IPO Registar Details
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: ravelcare.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
FAQs
The key objectives of Ravelcare SME IPO are:
- Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand
- Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”)
- General Corporate Purposes
Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. is the book-running lead managers for the Ravelcare IPO.
Ravelcare IPO shows strong growth potential driven by India’s rapidly expanding beauty and personal care market rising D2C adoption and growing international demand. Its data driven personalization high website traffic increasing repeat orders and upcoming in house manufacturing facility collectively support scalable expansion and stronger margin visibility.
The issue price for the Ravelcare IPO is set between ₹123 to ₹130 per share.
To invest in two lot of Ravelcare IPO, you need ₹2,46,000 at the lower price band (₹123 per share) or ₹2,60,000 at the upper price band (₹130 per share) for a lot size of 2000 shares.
Ravelcare IPO shares are scheduled to be listed on the Bombay Stock Exchange (BSE) on December 8, 2025.
Refund/unblocking of funds for Ravelcare IPO will begin on December 5, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Ravelcare IPO shares on listing day (December 8, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.